What are the recommended antibiotics for acute bacterial sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Antibiotics for Acute Bacterial Sinusitis

Amoxicillin-clavulanate is the preferred first-line antibiotic for acute bacterial sinusitis in adults, dosed at 875 mg/125 mg twice daily for 5-10 days. 1

First-Line Antibiotic Selection

The choice between amoxicillin alone versus amoxicillin-clavulanate depends on recent antibiotic exposure and disease severity:

Standard First-Line Options

  • Amoxicillin-clavulanate 875 mg/125 mg twice daily is recommended as the primary choice due to increasing prevalence of beta-lactamase-producing organisms (H. influenzae and M. catarrhalis) 1, 2
  • Plain amoxicillin 500 mg twice daily (for mild disease) or 875 mg twice daily (for moderate disease) remains acceptable for uncomplicated cases without recent antibiotic exposure 1, 2
  • The 2015 American Academy of Otolaryngology guideline allows either amoxicillin with or without clavulanate as first-line therapy 1

Treatment Duration

  • 5-10 days is the recommended duration, with most guidelines suggesting treatment until symptom-free for 7 days 1, 2
  • Shorter 5-7 day courses have comparable efficacy with fewer side effects 1
  • The traditional 10-14 day duration is still acceptable but may not provide additional benefit 2

Penicillin-Allergic Patients

For patients with documented penicillin allergy (non-Type I hypersensitivity):

  • Second-generation cephalosporins: cefuroxime-axetil 1, 2
  • Third-generation cephalosporins: cefpodoxime-proxetil or cefdinir 1, 2
  • Recent evidence shows the risk of serious allergic reactions to second- and third-generation cephalosporins in penicillin-allergic patients is negligible 1

Critical caveat: Azithromycin and other macrolides should NOT be used for acute bacterial sinusitis due to significant resistance patterns (20-25% bacterial failure rate), even in penicillin-allergic patients 1, 2

Second-Line Treatment for Failure

If no improvement occurs within 72 hours (pediatrics) 1 or 7 days (adults) 1:

Reassessment Required

  • Confirm the diagnosis of acute bacterial sinusitis 1
  • Exclude complications or alternative diagnoses 1
  • Consider imaging if not previously obtained 1

Second-Line Antibiotic Options

  • High-dose amoxicillin-clavulanate (if not already used) 2, 3
  • Respiratory fluoroquinolones: levofloxacin 500-750 mg daily or moxifloxacin 400 mg daily for 5-10 days 1, 2, 4
  • Fluoroquinolones demonstrate 90-92% clinical efficacy and 100% microbiologic eradication for S. pneumoniae, including multi-drug resistant strains 2, 4

Important limitation: Reserve fluoroquinolones for treatment failures, complicated sinusitis (frontal, ethmoidal, or sphenoidal involvement), or multi-drug resistant pathogens to prevent resistance development 2, 5

Treatment Based on Anatomic Location

Maxillary Sinusitis (Most Common)

  • Use standard first-line antibiotics (amoxicillin-clavulanate or amoxicillin) 2, 5
  • Presents with infraorbital pain worsening when bending forward, pulsatile quality, peaking evening/night 2

Frontal, Ethmoidal, or Sphenoidal Sinusitis

  • Fluoroquinolones (levofloxacin or moxifloxacin) are preferred due to higher risk of serious complications 2, 5
  • These locations warrant more aggressive initial therapy 2

Pediatric Dosing (Ages 1-18 Years)

Standard Therapy

  • Amoxicillin 45 mg/kg/day in 2 divided doses for mild disease without recent antibiotic use 1, 2
  • High-dose amoxicillin 80-90 mg/kg/day in 2 divided doses for areas with high prevalence of resistant S. pneumoniae, age <2 years, daycare attendance, or recent antibiotic use 1, 2

Alternative for Penicillin Allergy

  • Amoxicillin-clavulanate 90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses 1, 2
  • Cefpodoxime proxetil 8 mg/kg/day in two doses 2
  • Ceftriaxone 50 mg/kg as single dose for children unable to tolerate oral medication 2

Adjunctive Therapies

  • Intranasal corticosteroids are recommended as adjunct to antibiotic therapy in both acute and chronic sinusitis 2, 3, 5
  • Short-term oral corticosteroids (e.g., dexamethasone 4 mg) may be considered for acute hyperalgic sinusitis (severe pain) or marked mucosal edema 2, 3
  • Supportive measures include adequate hydration, analgesics, warm facial packs, and sleeping with head elevated 2

Watchful Waiting Option

For adults with uncomplicated acute bacterial sinusitis:

  • Watchful waiting without antibiotics is an appropriate initial strategy when follow-up can be assured 1
  • Start antibiotics if no improvement by 7 days or worsening at any time 1
  • This approach reduces adverse events and antibiotic resistance while maintaining comparable outcomes given favorable natural history (51% spontaneous improvement within 3 days on placebo) 1

Critical Pitfalls to Avoid

  • Do not use azithromycin or other macrolides as first-line therapy due to 20-25% resistance rates 1, 2
  • Do not routinely prescribe fluoroquinolones as initial therapy; reserve for treatment failures or complicated cases 2, 5
  • Ensure adequate treatment duration (minimum 5 days, typically 7-10 days) to prevent relapse 1, 2
  • Reassess at 3 days (pediatrics) or 7 days (adults) if no improvement to avoid treatment failure 1
  • Recent research shows high-dose amoxicillin-clavulanate (1750 mg amoxicillin twice daily) does NOT provide additional benefit over standard dosing (875 mg twice daily) and may increase diarrhea risk 6, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Acute Sinus Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Treatment for Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.